222 related articles for article (PubMed ID: 8095852)
61. Analysis of proliferative activity using antiproliferating cell nuclear antigen antibody in colorectal cancer.
Nakae S; Nakamura T; Shirono J; Yoshioka H; Ikegawa R; Miyamura K; Kawasaki K; Saitoh Y; Tabuchi Y
J Surg Oncol; 1995 Nov; 60(3):149-53. PubMed ID: 7475063
[TBL] [Abstract][Full Text] [Related]
62. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
63. Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer.
Shrestha P; Yamada K; Wada T; Maeda S; Watatani M; Yasutomi M; Takagi H; Mori M
Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):193-202. PubMed ID: 1357812
[TBL] [Abstract][Full Text] [Related]
64. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
[TBL] [Abstract][Full Text] [Related]
65. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
66. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
67. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
[TBL] [Abstract][Full Text] [Related]
68. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
[TBL] [Abstract][Full Text] [Related]
69. Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?
Thomas H; Nasim MM; Sarraf CE; Alison MR; Love S; Lambert HE; Price P
Br J Cancer; 1995 Feb; 71(2):357-62. PubMed ID: 7841053
[TBL] [Abstract][Full Text] [Related]
70. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
71. [Correlationship between proliferating cell nuclear antigen (PCNA) expression and clinicopathological factors in colorectal cancer].
Shirono J; Nakamura T; Nakae S; Saito Y
Nihon Geka Gakkai Zasshi; 1995 Dec; 96(12):787-91. PubMed ID: 8587571
[TBL] [Abstract][Full Text] [Related]
72. Proliferation-associated nucleolar antigen P120: a prognostic marker in node-negative breast cancer.
McGrath PC; Holley DT; Hamby LS; Powell DE; Mattingly C; Freeman JW
Surgery; 1994 Oct; 116(4):616-20; discussion 20-1. PubMed ID: 7940158
[TBL] [Abstract][Full Text] [Related]
73. Assessment of proliferating cell nuclear antigen (PCNA) immunoreactivity in exocrine pancreatic carcinomas.
Seki H; Konstantinidou AE; Papaevangelou M; Apostolikas N; Parassi E; Koyama K; Lygidakis N
Anticancer Res; 1993; 13(6B):2393-7. PubMed ID: 7907849
[TBL] [Abstract][Full Text] [Related]
74. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
75. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence.
Ogawa J; Tsurumi T; Yamada S; Koide S; Shohtsu A
Cancer; 1994 Feb; 73(4):1177-83. PubMed ID: 7906193
[TBL] [Abstract][Full Text] [Related]
76. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
[TBL] [Abstract][Full Text] [Related]
77. MCM-2, Ki-67 and PCNA protein expressions in pT3G2 colorectal cancer indicated lymph node involvement.
Guzińska-Ustymowicz K; Stepień E; Kemona A
Anticancer Res; 2008; 28(1B):451-7. PubMed ID: 18383884
[TBL] [Abstract][Full Text] [Related]
78. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
[TBL] [Abstract][Full Text] [Related]
79. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
80. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
